Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 3 8Phase 1/2 4Phase 4 3Phase 1 2Phase 2/3 1

Status

Completed 6Terminated 4Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3Breast 1

Conditions

Prostatic Neoplasms 3Premenopausal Breast Cancer 1

Interventions

pembrolizumab 75Carboplatin 61Cyclophosphamide 58Nivolumab 50Paclitaxel 47Gemcitabine 44Cisplatin 43Dexamethasone 41Radiotherapy 35Rituximab 32Capecitabine 31Docetaxel 29Bevacizumab 29fludarabine 27atezolizumab 26Cytarabine 26avelumab 24Trastuzumab 23Oxaliplatin 23Lenalidomide 23Cetuximab 23venetoclax 22Fluorouracil 22Azacitidine 22Temozolomide 21Ipilimumab 21130-nm albumin-bound paclitaxel 21fludarabine phosphate 20Filgrastim 20Bortezomib 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Terminated × Leuprolide × Clear all
NCT02990845 2023-02-22

PEER

National Taiwan University Hospital

Phase 1/2 Terminated
16 enrolled
Breast

Premenopausal Breast Cancer

NCT01163084 2019-02-28

Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer

National Cancer Institute (NCI)

Phase 1/2 Terminated
10 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT00924807 2018-12-11

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Beth Israel Medical Center

Phase 1/2 Terminated
4 enrolled 4 charts
Genitourinary

Prostatic Neoplasms

NCT01132404 2012-01-31

Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448

Millennium Pharmaceuticals, Inc.

Phase 1/2 Terminated
9 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡